These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32693407)

  • 1. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.
    Sims MC; Mayer L; Collins JH; Bariana TK; Megy K; Lavenu-Bombled C; Seyres D; Kollipara L; Burden FS; Greene D; Lee D; Rodriguez-Romera A; Alessi MC; Astle WJ; Bahou WF; Bury L; Chalmers E; Da Silva R; De Candia E; Deevi SVV; Farrow S; Gomez K; Grassi L; Greinacher A; Gresele P; Hart D; Hurtaud MF; Kelly AM; Kerr R; Le Quellec S; Leblanc T; Leinøe EB; Mapeta R; McKinney H; Michelson AD; Morais S; Nugent D; Papadia S; Park SJ; Pasi J; Podda GM; Poon MC; Reed R; Sekhar M; Shalev H; Sivapalaratnam S; Steinberg-Shemer O; Stephens JC; Tait RC; Turro E; Wu JKM; Zieger B; ; Kuijpers TW; Whetton AD; Sickmann A; Freson K; Downes K; Erber WN; Frontini M; Nurden P; Ouwehand WH; Favier R; Guerrero JA
    Blood; 2020 Oct; 136(17):1956-1967. PubMed ID: 32693407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
    Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
    Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.
    Kahr WH; Lo RW; Li L; Pluthero FG; Christensen H; Ni R; Vaezzadeh N; Hawkins CE; Weyrich AS; Di Paola J; Landolt-Marticorena C; Gross PL
    Blood; 2013 Nov; 122(19):3349-58. PubMed ID: 23861251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray Platelet Syndrome Presenting With Pancytopenia, Splenomegaly, and Bone Marrow Fibrosis.
    Tariq H; Perez Botero J; Higgins RA; Medina EA
    Am J Clin Pathol; 2021 Jul; 156(2):253-258. PubMed ID: 33586768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
    Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
    Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NBEAL2 mutations and bleeding in patients with gray platelet syndrome.
    Pluthero FG; Di Paola J; Carcao MD; Kahr WHA
    Platelets; 2018 Sep; 29(6):632-635. PubMed ID: 29869935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deep Dive into the Pathology of Gray Platelet Syndrome: New Insights on Immune Dysregulation.
    Glembotsky AC; De Luca G; Heller PG
    J Blood Med; 2021; 12():719-732. PubMed ID: 34408521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice.
    Tomberg K; Khoriaty R; Westrick RJ; Fairfield HE; Reinholdt LG; Brodsky GL; Davizon-Castillo P; Ginsburg D; Di Paola J
    PLoS One; 2016; 11(3):e0150852. PubMed ID: 26950939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome.
    Collins JH; Mayer L; Guerrero Lopez JA
    J Thromb Haemost; 2023 Jun; 21(6):1409-1419. PubMed ID: 37028650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.
    Bottega R; Pecci A; De Candia E; Pujol-Moix N; Heller PG; Noris P; De Rocco D; Podda GM; Glembotsky AC; Cattaneo M; Balduini CL; Savoia A
    Haematologica; 2013 Jun; 98(6):868-74. PubMed ID: 23100277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules.
    Gunay-Aygun M; Falik-Zaccai TC; Vilboux T; Zivony-Elboum Y; Gumruk F; Cetin M; Khayat M; Boerkoel CF; Kfir N; Huang Y; Maynard D; Dorward H; Berger K; Kleta R; Anikster Y; Arat M; Freiberg AS; Kehrel BE; Jurk K; Cruz P; Mullikin JC; White JG; Huizing M; Gahl WA
    Nat Genet; 2011 Jul; 43(8):732-4. PubMed ID: 21765412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil specific granule and NETosis defects in gray platelet syndrome.
    Aarts CEM; Downes K; Hoogendijk AJ; Sprenkeler EGG; Gazendam RP; Favier R; Favier M; Tool ATJ; van Hamme JL; Kostadima MA; Waller K; Zieger B; van Bergen MGJM; Langemeijer SMC; van der Reijden BA; Janssen H; van den Berg TK; van Bruggen R; Meijer AB; Ouwehand WH; Kuijpers TW
    Blood Adv; 2021 Jan; 5(2):549-564. PubMed ID: 33496751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome.
    Cao L; Su J; Li J; Yu Z; Bai X; Wang Z; Xia L; Ruan C
    Platelets; 2018 May; 29(3):288-291. PubMed ID: 28504079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.
    Guerrero JA; Bennett C; van der Weyden L; McKinney H; Chin M; Nurden P; McIntyre Z; Cambridge EL; Estabel J; Wardle-Jones H; Speak AO; Erber WN; Rendon A; Ouwehand WH; Ghevaert C
    Blood; 2014 Dec; 124(24):3624-35. PubMed ID: 25258341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NBEAL2 is required for neutrophil and NK cell function and pathogen defense.
    Sowerby JM; Thomas DC; Clare S; Espéli M; Guerrero JA; Hoenderdos K; Harcourt K; Marsden M; Abdul-Karim J; Clement M; Antrobus R; Umrania Y; Barton PR; Flint SM; Juss JK; Condliffe AM; Lyons PA; Humphreys IR; Chilvers ER; Ouwehand WH; Dougan G; Smith KG
    J Clin Invest; 2017 Sep; 127(9):3521-3526. PubMed ID: 28783043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte α-granule biogenesis.
    Lo RW; Li L; Pluthero FG; Leung R; Eto K; Kahr WHA
    Blood; 2020 Aug; 136(6):715-725. PubMed ID: 32384141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet α-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice.
    Tariket S; Guerrero JA; Garraud O; Ghevaert C; Cognasse F
    Transfusion; 2019 Jan; 59(1):32-38. PubMed ID: 30394544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome?
    Nurden AT; Nurden P
    Am J Hematol; 2016 Jul; 91(7):714-8. PubMed ID: 26971401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome.
    Kahr WH; Hinckley J; Li L; Schwertz H; Christensen H; Rowley JW; Pluthero FG; Urban D; Fabbro S; Nixon B; Gadzinski R; Storck M; Wang K; Ryu GY; Jobe SM; Schutte BC; Moseley J; Loughran NB; Parkinson J; Weyrich AS; Di Paola J
    Nat Genet; 2011 Jul; 43(8):738-40. PubMed ID: 21765413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-granule biogenesis: from disease to discovery.
    Chen CH; Lo RW; Urban D; Pluthero FG; Kahr WH
    Platelets; 2017 Mar; 28(2):147-154. PubMed ID: 28277061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.